Shea, M., Huberman, M. S., & Costa, D. B. (2016). Lazarus-type response to crizotinib in a patient with poor performance status and advanced MET exon 14 skipping mutation-positive lung adenocarcinoma. J Thorac Oncol.
Citación estilo ChicagoShea, Meghan, Mark S. Huberman, and Daniel B. Costa. "Lazarus-type Response to Crizotinib in a Patient With Poor Performance Status and Advanced MET Exon 14 Skipping Mutation-positive Lung Adenocarcinoma." J Thorac Oncol 2016.
Cita MLAShea, Meghan, Mark S. Huberman, and Daniel B. Costa. "Lazarus-type Response to Crizotinib in a Patient With Poor Performance Status and Advanced MET Exon 14 Skipping Mutation-positive Lung Adenocarcinoma." J Thorac Oncol 2016.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.